ADORA2A and Parkinson disease: On the other hand, the inhibition of A2aR by molecules like caffeine leads to an increase in dopaminergic activity, which makes antagonists of A2aR an important target for treating Parkinson’s [57] and Alzheimer’s diseases [58, 59].